Medical Letter on the CDC & FDA articles from January 2 2005

Medical Letter on the CDC & FDA archives from January 2 2005

Effects of drugs for space motion sickness on memory in humans examined.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Investigators have examined the effects of drug countermeasures for space motion sickness on working memory in humans. "Space motion sickness (SMS) is a problem during the first 72 hours of space...

Participation in mass treatment against filariasis in Haiti examined.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers describe the factors associated with participation in a campaign of mass treatment against lymphatic filariasis in Leogane, Haiti in a recent issue of the Annals of Tropical Medicine and...

Malaria-related deaths among U.S. travelers reported.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Investigators report malaria-related deaths among U.S. travelers in 1963-2001 in a recent issue of the Annals of Internal Medicine. According to a study from the United States, "Nearly 1,500...

Influence of geometry on fluorescence spectroscopy in tissue examined.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the influence of illumination-collection geometry on fluorescence spectroscopy in multilayer tissue. "Device-tissue interface geometry influences both the intensity of...

Method for selecting retroviral-producing cells developed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Scientists have developed a convenient method for positive selection of retroviral-producing cells generating vectors devoid of selectable markers. According to a study from the United States,...

U.S. FDA committee recommends accelerated clofarabine approval for ALL.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- ILEX Oncology, Inc., (ILXO) announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) positively endorsed clofarabine for the treatment of refractory or...

U.S. FDA clears Comet and Polaris DS Systems for permanent hair reduction.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Syneron Medical, Ltd., (ELOS), and its North American subsidiary Syneron, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted 510k marketing clearance to Syneron's Comet and...

U.S. FDA expands clearance for Smoothbeam laser.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Candela Corp. (CLZR) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Smoothbeam diode laser for the treatment of sebaceous hyperplasia, adding to...

Pharma company files data with U.S. FDA for Alzheimer urine test.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced that it has filed an amendment to its premarket approval application (PMA) for the company's urine NTP test kit with the U.S. Food and Drug...

Donepezil safe in patients with Alzheimer disease.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Donepezil has a good safety and tolerability record in patients with Alzheimer disease. "Cholinesterase (ChE) inhibitors, which prevent the hydrolysis of acetylcholine, have been approved for the...

Anti-rPA IgG ELISA for measuring antibody response in mice evaluated.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers have evaluated an anti-rPA IgG ELISA for measuring the antibody response in mice. According to a study from the United States, "A recombinant protective antigen (rPA)-based...

Antiviral agents against herpes and varicella-zoster viruses synthesized.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- 6-Azapyrimidine-2'-deoxy-4'-thionucleosides are antiviral agents against TK+ and TK- herpes simplex virus (HSV) and varicella-zoster virus (VZV) strains. "The synthesis of a series of novel...

British regulators recommend restricted use of Effexor.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- British regulators recommended that physicians restrict the use of the anti-depressant Efexor because its use could have side effects for heart health and pose other risks that require more careful...

FDA clears topical antimicrobial product Investigational New Drug application.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- NovaCal Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for NVC-101, a novel topical antimicrobial...

Pharma company files application for asthma medication, secures MS patents.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Patch International Inc. (PAII: OTCBB, PQG: Berlin Bremen Stock Exchange) reported that Pharmaxis (PXS: Australian Stock Exchange) has announced the filing of an Investigational New Drug (IND)...

Epitopes in Besnoitia besnoiti endocytes identified.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Monoclonal antibodies help identify two neutralization-sensitive epitopes in Besnoitia besnoiti endocytes. "Four monoclonal antibodies were produced against endozoite membrane and cytoplasmic...

Botulism resulting from toxic feed affects 52,000 foxes and minks in Finland.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Type C botulism resulting from toxic feed affected 52,000 farmed foxes and minks in Finland. "The largest reported outbreak of type C botulism in fur production animals is described....

U.S. FDA grants orphan drug status to monoclonal antibody for brain cancer.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- YM BioSciences Inc. (YMI), a cancer drug development company, and its subsidiary CIMYM Inc., announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted...

Criteria for breast implant removal without replacement outlined.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- A scientist reports 'out points' criteria for breast implant removal without replacement and criteria to minimize reoperations following breast augmentation in a recent issue of Plastic and...

Management algorithms to address breast implant concerns developed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Scientists have developed decision and management algorithms to address patient and Food and Drug Administration concerns regarding breast augmentation and implants. According to recent research...

PMA submitted for next-generation silicone gel-filled breast implants.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Inamed Corporation (NASDAQ:IMDC) announced on December 6, 2004, two significant events affecting its Breast Aesthetics franchise: 1) it has submitted a premarket approval application (PMA) with the...

CIA-funded venture group inks deal with fluidic circuit technology company.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Fluidigm, a pioneer in the field of miniaturized integrated fluidic circuit technology, announced that it has signed a strategic development deal with In-Q-Tel, a private venture group funded by the...

Pharma company announces financial results.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- OSI Pharmaceuticals, Inc., (NASDAQ: OSIP) announced its financial results for the company's fiscal year ended September 30, 2004. The company reported a net loss of $260.4 million (or $6.50 per...

Pharma companies partner to market Omacor.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Reliant Pharmaceuticals, Inc., and Pronova Biocare AS announced that the two companies have reached agreement for Reliant to market Omacor (omega-3 acid ethyl esters) in the U.S. following the product's...

FDA grants approval for new Atrovent HFA.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration has approved new Atrovent HFA (ipratropium bromide HFA) Inhalation Aerosol indicated as a bronchodilator...

Company files IND with U.S. FDA for T-cell clinical trials.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Stem-cell biotechnology and immunotherapy company CyGenics, Ltd., (CYN) announced that it had filed an investigational new drug application (IND) with the U.S. Food & Drug Administration (FDA). ...

Data shows Aranesp every 2 weeks is comparable once-a-week dose.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Amgen Inc. (NASDAQ:AMGN) announced that data published online in The Oncologist from a study analyzing three identical head-to-head trials show that 200 mcg of Aranesp (darbepoetin alfa) dosed once...

MammoTest Breast Biopsy System cleared as platform for breast brachytherapy.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Fischer Imaging Corp. (FIMG:PK), announced it has received clearance from the U.S. Food and Drug Administration (FDA) for use of the MammoTest Breast Biopsy System as a platform for interstitial breast...

Pharma company announces beta blocker trial did not meet endpoint.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Penwest Pharmaceuticals Co. (NASDAQ:PPCO) announced that in its efficacy trial of the low dose strength of PW2101, a beta blocker intended for the treatment of hypertension and angina, PW2101 did not...

NIH-funded study seeks volunteers to test effect of phone support for caregivers.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Earlier this year Yvonne Soares left her job as a fourth-grade teacher so she could care full-time for her sister, who has severe cerebral palsy. Soares, 55, spends her days helping her sister eat,...

Proteome comparison of Vibrio cholerae cultures reported.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Scientists have completed a proteome comparison of Vibrio cholerae cultured under aerobic and anaerobic conditions. "The pathogen Vibrio cholerae causes severe diarrheal disease in humans. This...

Genetics of biosynthesis of Vibrio cholerae lipopolysaccharides reviewed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers review the genetics of the biosynthesis of Vibrio cholerae lipopolysaccharides in a recent issue of Biochimica Et Biophysica Acta - Molecular Basis of Disease. According to a study from...

Incidence of coccidioidomycosis 6 to 32% during desert training.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The seroincidence of coccidioidomycosis ranges from 6 to 32% during military desert training exercises. According to a study from the United States, "Coccidioidomycosis is a common fungal infection...

Environmental effects on brain plasticity during aging reviewed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers review environmental influences on cognitive and brain plasticity during aging in a recent issue of the Journals of Gerontology Series A - Biological Sciences and Medical Sciences. "In...

Association of nut and seed intake with cancer risk studied.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- According to researchers with the World Health Organization (WHO), "A link between unsaturated fatty acids or phytonutrients and reduced risk of colorectal cancer has been suggested. However, the...

Data show ELOXATIN-based therapy combined with Bevacizumab improves survival.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Podvin +331-53-77-4223 Patients who received ELOXATIN-based chemotherapy (FOLFOX4) plus bevacizumab (Avastin) showed a statistically significant improvement in overall survival in a large...

Hange-Shashin-to is beneficial for treatment of experimental colitis.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Hange-Shashin-to is beneficial for treatment of experimental colitis. "Hange-shashin-to (HST) has been used as an herbal formula to treat inflammatory ulcerative gut diseases complicated with...

Namibia: Female condom still has a long way to go.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- A study on condom use in Namibia, conducted by the National Social Marketing Programme (NASOMA), said consumers found the female condom, the "femidom", was not readily available, and complained of its...

Biopharma company files IND with U.S. FDA for cystic fibrosis treatment.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Medical Discoveries, Inc., (BULLETIN BOARD: MLSC) announced that it has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for a phase I clinical trial...

Infection/dissemination of Dengue virus from recent mosquito species is low.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The infection and dissemination of Dengue virus from a recently introduced mosquito species in Brazil is relatively low. According to published research from Brazil, "In Brazil, dengue viruses...

Predictive markers identified for dengue shock syndrome.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Predictive markers have been identified for dengue shock syndrome. "An alarming rise of dengue has been seen in Mumbai during the post-monsoon season. We undertook this prospective study in the...

U.S. FDA lifts clinical hold on new treatment for prevention of dental caries.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Oragenics, Inc., (ONI) reported that the U.S. Food and Drug Administration (FDA) has agreed to lift the clinical hold on the company's Replacement Therapy for the treatment of dental caries. The...

FDA review period extension for chromium picolinate announced.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Nutrition 21, Inc., (Nasdaq:NXXI) announced that the U.S. Food and Drug Administration (FDA) officially posted Nutrition 21's acceptance of a 90-day extension for the FDA to review the company's health...

Company commences ComfortScan trials for final module of PMA.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- DOBI Medical International, Inc., (DBMI.OB) has initiated the clinical trial which will be the subject of the fifth and final module of its premarket approval (PMA) application with the U.S. Food and...

Zimbabwe: Women activists appeal for domestic violence legislation.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Zimbabwean women activists planned to petition their parliament on December 10, 2004, to approve a 4-year-old Prevention of Domestic Violence Bill, reported the UN Integrated Regional Information...

Clinical trials for agent to treat methamphetamine addiction initiated.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Yaupon Therapeutics, a specialty pharmaceutical company developing products for central nervous system disorders and cancer, has initiated a phase 1 trial for lobeline for the treatment of...

Programmed polymeric devices for pulsed drug delivery reviewed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Scientists have reviewed programmed polymeric devices for pulsed drug delivery in a recent issue of Pharmaceutical Research. "Pharmaceutical research strives to design drug delivery systems that...

Pharmaceutical firm reviews clinical pipeline.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) said at a meeting with the investment community that the company is on track to submit three regulatory submissions for three internally discovered compounds by the...

Synthetic molecules modulate transcription and differentiation.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Synthetic molecules that modulate transcription and differentiation provide insights for future drug discovery. According to recent research published in the journal Combinatorial Chemistry and...

Almost half of Americans use at least one prescription drug.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- America's medicine cabinets are more crowded than ever, with almost half of all people taking at least one prescription medicine and one in six taking three or more medications, according to the U.S....

Statement outlines recommendations to advance research and improve care.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Despite progress in end-of-life research, important aspects of this life stage remain poorly understood, according to a panel convened by the U.S. National Institutes of Health. The panel found...

Little evidence to link mercury fillings to human health problems.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Regardless of how you approach a trip to the dentist, you can take comfort in a new report, which concludes that the peer-reviewed scientific and medical literature published since 1996 reveals little...

Occurrence of super spreading events of SARS predicted by statistical analysis.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The occurrence of super spreading events of SARS is predicted by statistical analysis. According to scientists writing in the American Journal of Epidemiology, "One of the intriguing characteristics...

Equine encephalitis virus adaptation to epizootic vectors influence spread.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Venezuelan equine encephalitis virus adaptation to epizootic vectors may influence the spread of disease. According to recent research published in the Journal of Medical Entomology, "To test the...

Complete nucleotide sequence determined for drug resistant E. coli outbreak.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The complete nucleotide sequence was determined for a drug resistant E. coli outbreak. "A major outbreak involving an Escherichia coli strain that was resistant to expanded-spectrum cephalosporins...

Gender-regulated transcripts in Brugia malayi by real-time PCR analyzed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers have conducted a quantitative analysis of gender-regulated transcripts in the filarial nematode Brugia malayi by real-time RT-PCR. According to a study from the United States, "Improved...

Model of sensitization and oral tolerance to peanut protein developed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Scientists have developed a novel model of sensitization and oral tolerance to peanut protein. According to published research from England, "The prevalence of food allergic diseases is rising and...

U.S. FDA denies soft drink industry request regarding ingredients.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- In a November 26, 2004 action, the U.S. Food and Drug Administration (FDA) withdrew the soft drink industry's 1993 special exemption request to use "and/or" labeling on soft drinks, reaffirming it is...

FDA releases study on presence of perchlorate in food and water supply.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) published initial exploratory data looking at the presence of the chemical perchlorate in some of our nation's food and water supply. The FDA reported...

U.S. FDA: Use of virginiamycin in animals no significant threat to human health.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Phibro Animal Health Corp. announced that the Center for Veterinary Medicine of the U.S. Food and Drug Administration (FDA) has released the findings of its draft risk assessment for the animal drug...

NEXIUM now indicated for reduced risk of gastric ulcers.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that a new indication for its prescription acid inhibitor NEXIUM (esomeprazole magnesium) has been approved by the U.S. Food and Drug Administration (FDA). NEXIUM is now...

PillCam ESO receives marketing clearance from U.S. FDA.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has given marketing clearance to the new PillCam ESO. PillCam ESO is a miniature color video camera in a pill that helps doctors diagnose and evaluate...

Child health must become UNICEF's priority over next decade.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- As a high-level forum assessing the progress on global health in relation to the millennium development goals recently concluded in Abuja, Nigeria, the rhetoric of success repeated by those charged with...

Life science company receives additional U.S. FDA clearance for quality controls.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- SeraCare Life Sciences, Inc. (SRLS) announced U.S. Food and Drug Administration (FDA) clearance for three new Accurun quality controls sold through SearCare's BBI diagnostics division. The Accurun...

HIV risk perceptions in adolescents often tied to household relationships.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- HIV risk perceptions in adolescents are often tied to household relationships. "Risk perception has been theorized to be an important antecedent for adopting protective behavior. It is a key...

Internet is useful/low cost for recruiting and assessing HIV sexual risks.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The Internet is a useful and low cost option for recruiting and assessing HIV sexual risks in a subgroup of men who have sex with men. According to published research from the United States, "The...

Negotiation strategies increase female condom use in relationships.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Negotiation strategies increase female condom use in relationships. According to published research from the United States, "Safe sex skills training often teach women to be assertive in condom use...

Prevention intervention increases safe sex practices in HIV+ substance users.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Prevention intervention programs increase safe sex practices in HIV+ substance users. "HIV risky behaviors and health practices were examined among young people living with HIV (YPLH) in Los...

Syringe distribution based on need facilitates reductions in needle reuse.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Syringe distribution based on need facilitates reductions in needle reuse. "While there have been numerous papers published in the medical, social, and epidemiologic literature about the...

Government criticized over Aboriginal community aid plan.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The Australian government has been accused of humiliating an outback Aboriginal community with a demand that indigenous children wash their faces twice a day to promote public health if the town is to...

Healthcare use by U.S. veterans with spinal cord injury studied.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- According to a recent study, "In the USA, substantial geographic variation in healthcare utilization exists in the Department of Veterans Affairs (VA) healthcare system. "Utilization of healthcare...

Pathophysiology of heat stroke reviewed.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers review the epidemiology and pathophysiology of heat stroke in a recent issue of the Journal of Thermal Biology. According to a study from Japan, "Biological functions are basically...

Apoptosis induced by hepatitis A virus dependent on caspase activation.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Apoptosis induced by a cytopathic hepatitis A virus is dependent on caspase activation following ribosomal RNA degradation but occurs in the absence of 2'-5' oligoadenylate synthetase. "We have...

Study examined how hypohydration alters thermoregulatory responses in the heat.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the influence of hydration and airflow on thermoregulatory control in the heat. According to a study from the United States, "Exercise-heat exposure results in...

Approvable letter issued for conivaptan hydrochloride injection for hyponatremia.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Yamanouchi Pharma America, Inc., a subsidiary of Yamanouchi Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for conivaptan...

U.S. FDA grants approval for investigational drug to treat hyponatremia.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Yamanouchi Pharmaceutical Co., Ltd. announced that its U.S. subsidiary, Yamanouchi Pharma America Inc. (YPA), Paramus, New Jersey, has received an approvable letter for YM087, an investigational drug to...

Management of infant infiltration injury using hydroactive gel outlined.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers describe the management of infiltration injury in neonates using DuoDerm hydroactive gel in a recent issue of the American Journal of Perinatology. According to published research from...

Foreign flu shots coming to U.S.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- The U.S. government is pressing to buy more flu vaccine despite a slow start to the flu season. The U.S. Food and Drug Administration (FDA) has signed off on the safety of a portion of 5 million...

Britain extends suspension of flu vaccine maker's license.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- A vaccine manufacturer whose license was suspended in October, plunging U.S. supplies of flu shots into crisis, will remain on hold for another 3 months to allow the firm more time to take remedial...

Software helps children and adults with disabilities "point and click".
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Using a computer mouse can be a difficult and embarrassing task for children and adults with disabilities affecting fine motor skills. But a new software application, available soon, promises to...

Challenges facing islet transplantation for treating type 1 diabetes reported.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Researchers report the challenges facing islet transplantation for the treatment of type 1 diabetes in a recent issue of the Journal of Clinical Investigation. According to a study from the United...

Researcher studying lead levels in St. Louis kids.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Roughly 200,000 houses in St. Louis might as well have the cross-stitched phrase "Home, sweet (and toxic), home" hanging in a frame on their living room wall, according to a University of Missouri-Rolla...

Construction sites yield elusive malaria vector.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Construction sites yield an elusive malaria vector. "Malaria in Goa, India, has been endemic ever since an outbreak occurred in 1986. Anopheles stephensi Liston has always been suspected as a...

Complex between Plasmodium protein and antibody Fab fragment described.
January 2, 2005... 2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Scientists have characterized a complex between the Plasmodium vivax sexual stage 25-kDa protein Pvs25 and a malaria transmission-blocking antibody Fab fragment. According to recent research from...